Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Tepha Inc. Announces the Presentation of Pre-Clinical and Clinical Data on the Use of P4HB™ Regenerative Scaffolds In Urogynecology


News provided by

Tepha Inc.

25 Sep, 2019, 13:08 GMT

Share this article

Share toX

Share this article

Share toX

LEXINGTON, Massachusetts, Sept. 25, 2019 /PRNewswire/ -- A leader and innovator in the fast-growing field of fully resorbable scaffolds that support soft tissue regeneration, Tepha Inc., announced today that four abstracts will be presented at the upcoming combined meeting of the American Urogynecology Association (AUGS) and the International Urogynecology Association (IUGA) in Nashville, TN on September 24th-28th, which evaluate the use of the company's proprietary fully resorbable poly-4-hydroxybutyrate (P4HB) polymer scaffold for Female Pelvic Health applications. Fully resorbable scaffolds manufactured from Tepha's P4HB polymer were first introduced in 2012 and have now been safely used in more than 200,000 surgical procedures around the world in both complex abdominal wall reconstruction as well as plastic and reconstructive surgery applications.

In 2016 Tepha initiated an integrated bench, pre-clinical and clinical testing program in collaboration with urogynecological thought leaders on three continents, in an effort to design and develop P4HB scaffolds for the surgical treatment of Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP). P4HB scaffolds are designed to reinforce, resorb, and support the regeneration of a new functional tissue plane, thereby potentially reducing the development of chronic complications such as pain, erosion and infection that have been associated with permanent non-resorbable mesh devices.

The Tepha urogynecolgical program has been led by: Professor Jan Paul Roovers, Medical Director of the Bergman Clinic and Head of the Department of Gynaecology at the Academic Medical Center in Amsterdam;  Dr. Stephen Jeffery, Head of the Department of Urogynaecology and Pelvic Floor Reconstruction at the University of Cape Town, South Africa; and Dr. Harvey Winkler, System Chief of the Division of Female Pelvic Medicine and Reconstructive Surgery at Northwell Health and Professor in the Department of Obstetrics and Gynecology at the Zucker School of Medicine at Hofstra/Northwell.  The joint research program initially focused on the evaluation and comparison of the histological and biomechanical properties of various P4HB scaffold designs for SUI and POP as compared to existing commercially available polypropylene mesh devices following implantation in both large and small animal models. In both the short (six months) and long term (up to 18 month) studies, P4HB scaffolds were demonstrated to be biocompatible, successfully encouraged the regeneration of connective tissue, provided mechanical support to the vaginal wall during the resorption period, and showed promise as an alternative graft material to polypropylene.

Dr. Harvey Winkler commented, "With the FDA's recent directive removing transvaginal mesh for the surgical management of pelvic organ prolapse in the United States, urogynecologists and patients alike are in need of a safe and effective alternative to native tissue repair.  After working with P4HB designs for the past two years I am very encouraged by the pre-clinical results we have evidenced and am optimistic that the P4HB resorbable polymer technology may eliminate the long term complications associated with non resorbable grafts and may lead to a new generation of safe and effective treatments for our patients."

After more than two years of pre-clinical research, co-investigators Dr. Stephen Jeffery and Professor Jan Paul Roovers, in conjunction with the Pelvic Floor Foundation of South Africa, initiated the first clinical application of Tepha's P4HB fully resorbable polymer scaffold for the surgical treatment of female SUI. The clinical abstract being presented at the combined AUGS/IUGA meeting this week, shows promise that a retropubically placed sling manufactured from P4HB could be a viable alternative to non-resorbable slings currently in use. 

Dr. Stephen Jeffery commented, "We are in our second year of patient enrolment, and with our first patients out more than one year at this point, I have been very pleased with the results evidenced by our team to date. All surgically treated patients are currently continent, with no evidence of device-related pain or erosion, which has previously been associated with non-resorbable scaffold designs."

Tepha's P4HB fully resorbable scaffolds are designed to resorb and remodel forming a new, natural tissue plane that provides support and long term strength to the repair site. The benefit of complete resorption of scaffolds engineered from P4HB may serve to reduce patients' concerns relative to complications associated with non resorbable materials.

Professor Jan Paul Roovers summarized, "Hundreds of thousands of women suffering from stress urinary incontinence and pelvic organ prolapse are currently being deprived of an optimal treatment for their serious clinical challenges. Our commitment and confidence in this technology is the result of the hard work of this multi-institutional collaboration, and we are very encouraged that P4HB scaffolds could be the technology that best serves this patient population."

About Tepha and P4HB

Tepha Inc., founded in 1998 and headquartered in Lexington, MA, is a supplier of medical devices focused on its proprietary P4HB polymer technology.  Tepha's products are designed and developed to elevate, support and reinforce soft tissue as well as to stimulate tissue healing and regenerative processes. Commercial mesh and suture products based on Tepha's resorbable P4HB polymer technology are currently utilized in the fields of hernia repair, orthopedic soft tissue repair, general wound repair, and plastic and reconstructive surgery through Tepha's wholly owned subsidiary, Galatea Inc.  Tepha and its partners have received 29 FDA 510(k) and 8 CE Mark clearances in the United States in Europe, respectively.  To date, products made from P4HB have been successfully used in more than 4,000,000 surgical procedures worldwide, and have been the subject of over 60 published clinical and scientific papers.

For more information visit: www.Tepha.com or contact: Andrew Joiner at joiner@tepha.com

Related Links

http://www.tepha.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.